These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37584270)

  • 1. MolSHAP: Interpreting Quantitative Structure-Activity Relationships Using Shapley Values of R-Groups.
    Tian T; Li S; Fang M; Zhao D; Zeng J
    J Chem Inf Model; 2024 Apr; 64(7):2236-2249. PubMed ID: 37584270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions.
    Rodríguez-Pérez R; Bajorath J
    J Comput Aided Mol Des; 2020 Oct; 34(10):1013-1026. PubMed ID: 32361862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized heuristic inverse quantitative structure activity relationship with bulk descriptors using numerical gradients.
    Stålring J; Almeida PR; Carlsson L; Helgee Ahlberg E; Hasselgren C; Boyer S
    J Chem Inf Model; 2013 Aug; 53(8):2001-17. PubMed ID: 23845139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General Approach to Estimate Error Bars for Quantitative Structure-Activity Relationship Predictions of Molecular Activity.
    Liu R; Glover KP; Feasel MG; Wallqvist A
    J Chem Inf Model; 2018 Aug; 58(8):1561-1575. PubMed ID: 29949366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive ensemble in QSAR prediction for drug discovery.
    Kwon S; Bae H; Jo J; Yoon S
    BMC Bioinformatics; 2019 Oct; 20(1):521. PubMed ID: 31655545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
    Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery.
    Li Z; Huang R; Xia M; Patterson TA; Hong H
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explainable Machine Learning for Property Predictions in Compound Optimization.
    Rodríguez-Pérez R; Bajorath J
    J Med Chem; 2021 Dec; 64(24):17744-17752. PubMed ID: 34902252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assisting Multitargeted Ligand Affinity Prediction of Receptor Tyrosine Kinases Associated Nonsmall Cell Lung Cancer Treatment with Multitasking Principal Neighborhood Aggregation.
    Nakarin F; Boonpalit K; Kinchagawat J; Wachiraphan P; Rungrotmongkol T; Nutanong S
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Analysis of QSAR Research Based on Machine Learning Concepts.
    Keyvanpour MR; Shirzad MB
    Curr Drug Discov Technol; 2021; 18(1):17-30. PubMed ID: 32178612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperbolic relational graph convolution networks plus: a simple but highly efficient QSAR-modeling method.
    Wu Z; Jiang D; Hsieh CY; Chen G; Liao B; Cao D; Hou T
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel DGAT1 inhibitors by combination of machine learning methods, pharmacophore model and 3D-QSAR model.
    Zhang H; Shen C; Zhang HR; Chen WX; Luo QQ; Ding L
    Mol Divers; 2021 Aug; 25(3):1481-1495. PubMed ID: 34160713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances with support vector machines for novel drug discovery.
    Maltarollo VG; Kronenberger T; Espinoza GZ; Oliveira PR; Honorio KM
    Expert Opin Drug Discov; 2019 Jan; 14(1):23-33. PubMed ID: 30488731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative research framework for the design of user-centered displays of explanations for machine learning model predictions in healthcare.
    Barda AJ; Horvat CM; Hochheiser H
    BMC Med Inform Decis Mak; 2020 Oct; 20(1):257. PubMed ID: 33032582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Machine-Learning-Based Chemoinformatics: A Comprehensive Review.
    Niazi SK; Mariam Z
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the scope of Free-Wilson analysis: building interpretable QSAR models with machine learning algorithms.
    Chen H; Carlsson L; Eriksson M; Varkonyi P; Norinder U; Nilsson I
    J Chem Inf Model; 2013 Jun; 53(6):1324-36. PubMed ID: 23789733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning in chemoinformatics and drug discovery.
    Lo YC; Rensi SE; Torng W; Altman RB
    Drug Discov Today; 2018 Aug; 23(8):1538-1546. PubMed ID: 29750902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of chemical-induced hematotoxicity with machine learning and deep learning methods.
    Hua Y; Shi Y; Cui X; Li X
    Mol Divers; 2021 Aug; 25(3):1585-1596. PubMed ID: 34196933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.